Table 6

Recommendations for residual disease after revascularisation

For return to flight duties, aircrew with revascularisation should have no residual haemodynamically significant disease. Highly recommended
Non-revascularised coronary artery disease burden, to include aggregate stenosis, should be calculated in non-obstructive disease to determine risk. Highly recommended
All aircrew with myocardial infarction and/or revascularisation should be limited to non-high performance airframes and for pilots, limited to dual pilot operations. Highly recommended
All aircrew must meet secondary risk factor recommendation goals for return to flight duties. Highly recommended